Literature DB >> 27997737

Distribution of type I corticotropin-releasing factor (CRF1) receptors on GABAergic neurons within the basolateral amygdala.

Katina C Calakos1, Dakota Blackman1, Alexandra M Schulz1, Elizabeth P Bauer1.   

Abstract

The neuropeptide corticotropin-releasing factor (CRF) plays a critical role in mediating anxiety-like responses to stressors, and dysfunction of the CRF system has been linked to the etiology of several psychiatric disorders. Extra-hypothalamic CRF can also modulate learning and memory formation, including amygdala-dependent learning. The basolateral nucleus of the amygdala (BLA) contains dense concentrations of CRF receptors, yet the distribution of these receptors on specific neuronal subtypes within the BLA has not been characterized. Here, we quantified the expression of CRF receptors on three nonoverlapping classes of GABAergic interneurons: those containing the calcium-binding protein parvalbumin (PV), and those expressing the neuropeptides somatostatin (SOM) or cholecystokinin (CCK). While the majority of PV+ neurons and roughly half of CCK+ neurons expressed CRF receptors, they were expressed to a much lesser extent on SOM+ interneurons. Knowledge of the distribution of CRF receptors within the BLA can provide insight into how manipulations of the CRF system modulate fear and anxiety-like behaviors.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27997737      PMCID: PMC7876706          DOI: 10.1002/syn.21953

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  90 in total

1.  Transneuronal labeling of a nociceptive pathway, the spino-(trigemino-)parabrachio-amygdaloid, in the rat.

Authors:  L Jasmin; A R Burkey; J P Card; A I Basbaum
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903.

Authors:  Michelle Yeung; Dallas Treit
Journal:  Pharmacol Biochem Behav       Date:  2011-12-22       Impact factor: 3.533

Review 3.  The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

Authors:  F Holsboer
Journal:  J Psychiatr Res       Date:  1999 May-Jun       Impact factor: 4.791

Review 4.  Contextual and temporal modulation of extinction: behavioral and biological mechanisms.

Authors:  Mark E Bouton; R Frederick Westbrook; Kevin A Corcoran; Stephen Maren
Journal:  Biol Psychiatry       Date:  2006-04-17       Impact factor: 13.382

5.  Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

Authors:  E Merlo Pich; M Lorang; M Yeganeh; F Rodriguez de Fonseca; J Raber; G F Koob; F Weiss
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

6.  Corticotropin-releasing factor neurotransmission in locus coeruleus: a possible site of antidepressant action.

Authors:  A L Curtis; R J Valentino
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

7.  Amygdala intercalated neurons are required for expression of fear extinction.

Authors:  Ekaterina Likhtik; Daniela Popa; John Apergis-Schoute; George A Fidacaro; Denis Paré
Journal:  Nature       Date:  2008-07-09       Impact factor: 49.962

8.  Decreased anxiety-like behavior and Gαq/11-dependent responses in the amygdala of mice lacking TRPC4 channels.

Authors:  Antonio Riccio; Yan Li; Evgeny Tsvetkov; Svetlana Gapon; Gui Lan Yao; Kiersten S Smith; Elif Engin; Uwe Rudolph; Vadim Y Bolshakov; David E Clapham
Journal:  J Neurosci       Date:  2014-03-05       Impact factor: 6.167

9.  Fear extinction learning can be impaired or enhanced by modulation of the CRF system in the basolateral nucleus of the amygdala.

Authors:  Dina Abiri; Christina E Douglas; Katina C Calakos; Georgia Barbayannis; Andrea Roberts; Elizabeth P Bauer
Journal:  Behav Brain Res       Date:  2014-06-16       Impact factor: 3.332

10.  Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study.

Authors:  S Cummings; R Elde; J Ells; A Lindall
Journal:  J Neurosci       Date:  1983-07       Impact factor: 6.167

View more
  5 in total

Review 1.  Amygdala, neuropeptides, and chronic pain-related affective behaviors.

Authors:  Volker Neugebauer; Mariacristina Mazzitelli; Bryce Cragg; Guangchen Ji; Edita Navratilova; Frank Porreca
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

Review 2.  Inhibition in the amygdala anxiety circuitry.

Authors:  Olga Babaev; Carolina Piletti Chatain; Dilja Krueger-Burg
Journal:  Exp Mol Med       Date:  2018-04-09       Impact factor: 8.718

Review 3.  Hyperexcitability: From Normal Fear to Pathological Anxiety and Trauma.

Authors:  Jeffrey B Rosen; Jay Schulkin
Journal:  Front Syst Neurosci       Date:  2022-08-04

4.  Electroacupuncture Ameliorates Chronic Inflammatory Pain-Related Anxiety by Activating PV Interneurons in the Anterior Cingulate Cortex.

Authors:  Fangbing Shao; Junfan Fang; Mengting Qiu; Sisi Wang; Danning Xi; Xiaomei Shao; Xiaofen He; Jianqiao Fang; Junying Du
Journal:  Front Neurosci       Date:  2021-07-05       Impact factor: 4.677

5.  Corticotropin-Releasing Factor Receptor-1 Neurons in the Lateral Amygdala Display Selective Sensitivity to Acute and Chronic Ethanol Exposure.

Authors:  Abigail E Agoglia; ManHua Zhu; Rose Ying; Harpreet Sidhu; Luis A Natividad; Sarah A Wolfe; Matthew W Buczynski; Candice Contet; Loren H Parsons; Marisa Roberto; Melissa A Herman
Journal:  eNeuro       Date:  2020-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.